Skip to main content
. 2018 Jun 12;9(13):2374–2379. doi: 10.7150/jca.26359

Table 3.

Association between NOTCH4 expression and clinicpathological factors in the validation cohort.

Variable n NOTCH4 Expression χ2 Value P value
Low High
Gender 1.132 0.287
Male 149 65(56.5) 84(63.2)
Female 99 50(43.5) 49(36.8)
Age 1.394 0.238
≦60 152 75(65.2) 77(57.9)
>60 96 40(34.8) 56(42.1)
T category 4.367 0.113
T1/2 36 23(20.2) 14(10.5)
T3 51 22(19.1) 29(21.8)
T4 160 70(60.9) 90(67.7)
N stage 12.795 0.002
N0 107 61(53.0) 46(34.6)
N1 81 25(21.7) 56(42.1)
N2 60 29(25.2) 31(23.3)
M stage 9.689 0.002
M0 215 108(93.9) 107(80.5)
M1 33 7(6.1) 26(19.5)
Pathological grading 2.225 0.329
High 69 28(24.3) 41(30.8)
Moderate 125 66(57.4) 59(44.4)
Poor 54 21(18.3) 33(24.8)
Lymphovascular invasion 4.718 0.030
Negative 194 97(84.3) 97(72.7)
Positive 54 18(15.7) 36(27.1)
Perineural invasion 0.007 0.933
Negative 213 99(86.1) 114(85.7)
Positive 35 16(13.9) 19(14.3)
CEA status 7.272 0.026a
Normal 157 83(72.2) 74(55.6)
High 82 29(25.2) 53(39.8)
Unknown 9 3(2.6) 6(4.5)

a exact χ2 test